Cargando…

Responsiveness of the EQ-5D in breast cancer patients in their first year after treatment

BACKGROUND/AIM: The EQ-5D is a generic health-related quality of life (HRQoL) measure that is used for the purpose of economic evaluations of health interventions. Therefore, it has to be responsive to meaningful changes in health in the patient population under investigation. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimman, Merel L, Dirksen, Carmen D, Lambin, Philippe, Boersma, Liesbeth J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669061/ https://www.ncbi.nlm.nih.gov/pubmed/19200391 http://dx.doi.org/10.1186/1477-7525-7-11

Ejemplares similares

Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer
por: Kimman, Merel L, et al.
Publicado: (2010)

Improving the quality and efficiency of follow-up after curative treatment for breast cancer – rationale and study design of the MaCare trial
por: Kimman, Merel L, et al.
Publicado: (2007)

Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments
por: Wolfs, Claire AG, et al.
Publicado: (2007)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

An investigation of age dependency in Dutch and Chinese values for EQ-5D-Y
por: Essers, Brigitte, et al.
Publicado: (2023)

EQ-5D-Y-5L: developing a revised EQ-5D-Y with increased response categories
por: Kreimeier, Simone, et al.
Publicado: (2019)

Age dependency of EQ-5D-Youth health states valuations on a visual analogue scale
por: Retra, Jim G. A., et al.
Publicado: (2020)

Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
por: Olariu, Elena, et al.
Publicado: (2023)

Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
por: Wille, Nora, et al.
Publicado: (2010)

NICE and the EQ-5D-5L: Ten Years Trouble
por: Sampson, Chris
Publicado: (2021)

Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe
por: Golicki, Dominik, et al.
Publicado: (2019)

Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
por: Gabbe, Belinda J, et al.
Publicado: (2015)

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
por: Herdman, M., et al.
Publicado: (2011)

Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults
por: Ferreira, Lara N., et al.
Publicado: (2016)

Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values
por: Selivanova, Anna, et al.
Publicado: (2018)

Comparing the performance of the EQ-5D-3 L and the EQ-5D-5 L in an elderly Chinese population
por: You, Ruxu, et al.
Publicado: (2020)

EQ-5D in skin conditions: an assessment of validity and responsiveness
por: Yang, Yaling, et al.
Publicado: (2014)

Developing an aftercare decision aid; assessing health professionals' and patients' preferences
por: Klaassen, Linda, et al.
Publicado: (2017)

First population norms for the EQ-5D-3L in the Russian Federation
por: Khabibullina, Alina, et al.
Publicado: (2022)

A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy
por: Wijnen, Ben F. M., et al.
Publicado: (2017)

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
por: Pattanaphesaj, Juntana, et al.
Publicado: (2015)

Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
por: Bató, Alex, et al.
Publicado: (2021)

Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran
por: Moradi, Nasrin, et al.
Publicado: (2022)

Correspondence between EQ-5D health state classifications and EQ VAS scores
por: Whynes, David K
Publicado: (2008)

Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
por: Yousefi, Mahmood, et al.
Publicado: (2016)

Validity of EQ-5D-5L in stroke
por: Golicki, Dominik, et al.
Publicado: (2014)

Valuation of the EQ-5D-5L in Taiwan
por: Lin, Hsiang-Wen, et al.
Publicado: (2018)

Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients
por: Fitriana, Titi Sahidah, et al.
Publicado: (2021)

Comparison of the EQ-5D-Y-5L, EQ-5D-Y-3L and PedsQL in children and adolescents
por: Verstraete, Janine, et al.
Publicado: (2022)

Quality of life after cardiac arrest - evaluation with EQ-5D
por: Granja, C, et al.
Publicado: (2001)

Outcome assessment after hip fracture: is EQ-5D the answer?
por: Parsons, N., et al.
Publicado: (2014)

Validation of the EQ-5D in Taiwan using item response theory
por: Liu, Tzu-Hung, et al.
Publicado: (2021)

EQ-5D Brazilian population norms
por: Santos, Marisa, et al.
Publicado: (2021)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

Belgian population norms for the EQ-5D-5L, 2018
por: Van Wilder, Lisa, et al.
Publicado: (2021)

Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care
por: Verstraete, Janine, et al.
Publicado: (2022)

Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys
por: Martí-Pastor, Marc, et al.
Publicado: (2018)

EQ-5D self-reported health in Barbados and Jamaica with EQ-5D-5L population norms for the English-speaking Caribbean
por: Bailey, Henry, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_famc7ish2mf0athkamfsbhvjhr